Phase 1a Study of TU7710 Following Single Dose Administration in Warfarin Anti-coagulated Healthy Male Subjects
Conditions: Hemophilia A; Hemophilia B; Blood Coagulation Disorders Interventions: Drug: TU7710; Drug: Normal saline Sponsor: TiumBio Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 6, 2023 Category: Research Source Type: clinical trials
Study of TU7710 in Warfarin Anti-coagulated Healthy Male Subjects
Conditions: Hemophilia A; Hemophilia B; Blood Coagulation Disorders Interventions: Drug: TU7710; Drug: Normal saline Sponsor: TiumBio Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 6, 2023 Category: Research Source Type: clinical trials
Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE
Conditions: Antiphospholipid Syndrome; Ischemic Stroke; Transient Ischemic Attack; Cerebrovascular Disease; Cardiovascular Diseases; Major Bleed Interventions: Drug: Antiplatelet Drug; Drug: Warfarin Sponsors: Seoul National University Hospital; Samjin Pharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2023 Category: Research Source Type: clinical trials